First in-human study of AMG 853 in healthy subjects

Trial Profile

First in-human study of AMG 853 in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs AMG-853 (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Amgen
  • Most Recent Events

    • 05 Nov 2010 New trial record.
    • 14 May 2010 Results presented at the 106th International Conference of the American Thoracic Society.
    • 26 Feb 2010 Results presented at the 66th Annual Meeting of the American Academy of Allergy, Asthma and Immunology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top